Welcome to SureStone Capital, formerly Ausbiz CapitalSame team, same ABN and AFS authorisations. Our name changed on 1 October 2026.

Health Care ASX Announcements

Plain-English summaries of selected price-sensitive ASX announcements in the Health Care sector. Every summary is drawn only from the company's official release.

Thursday, 1 October 2026

1 announcement

LTR Pharma Limited (ASX:LTP)
OperationsPrice Sensitive

LTR Pharma Confirms SPONTAN Phase II Final PK Data

LTR Pharma final SPONTAN Phase II report confirms median Tmax of 10 minutes versus 60 minutes for oral vardenafil and completes the FDA pharmacokinetic dataset.

LTR Pharma Limited (ASX:LTP)

8:24 am

1 Oct 2026

Wednesday, 30 September 2026

1 announcement

Telix Pharmaceuticals Limited (ASX:TLX)
ClinicalPrice Sensitive

Telix Wins FDA Fast Track for BiPASS Imaging

Telix receives FDA Fast Track for BiPASS pre-biopsy PSMA-PET with MRI, after completing Phase 3 enrollment for its Illuccix and Gozellix imaging agents.

Telix Pharmaceuticals Limited (ASX:TLX)

8:20 am

30 Sep 2026

Friday, 25 September 2026

1 announcement

Healius Limited (ASX:HLS)
OperationsPrice Sensitive

Healius to Sell Agilex Biolabs for A$160m EV

Healius agreed to sell Agilex Biolabs to a Novotech unit for an A$160m enterprise value, with completion expected in H2 FY2027 subject to FIRB and ACCC.

Healius Limited (ASX:HLS)

8:49 am

25 Sep 2026

Thursday, 24 September 2026

1 announcement

Mesoblast Limited (ASX:MSB)
ClinicalPrice Sensitive

Mesoblast FDA Approves New Ryoncil Potency Assay

Mesoblast received FDA approval for the TIBA potency assay to release commercial Ryoncil product lots alongside existing IL-2Rα inhibition and CAP assays.

Mesoblast Limited (ASX:MSB)

9:52 am

24 Sep 2026

Wednesday, 23 September 2026

1 announcement

Dimerix Limited (ASX:DXB)
OperationsPrice Sensitive

Dimerix Draws A$17m of A$34m Non-Dilutive Facility

Dimerix has drawn approximately A$17m under its A$34m non-dilutive facility, with a further A$17m available until 31 March 2027 to fund planned trials.

Dimerix Limited (ASX:DXB)

8:36 am

23 Sep 2026

Tuesday, 22 September 2026

1 announcement

Rhythm Biosciences Ltd (ASX:RHY)
OperationsPrice Sensitive

Rhythm Completes ColoSTAT NHS Tech Transfer Phase

Rhythm Biosciences says Royal Surrey NHS Southern Hub has completed ColoSTAT technology transfer; analytical evaluation is next, then a clinical study.

Rhythm Biosciences Ltd (ASX:RHY)

8:24 am

22 Sep 2026

Monday, 21 September 2026

1 announcement

Telix Pharmaceuticals Limited (ASX:TLX)
OperationsPrice Sensitive

Telix to Merge with ITM for US$1.65bn Upfront

Telix will lead a merger with ITM for US$1.65bn upfront cash-free/debt-free, plus up to US$700m contingent on ITM-11 milestones, subject to approvals.

Telix Pharmaceuticals Limited (ASX:TLX)

8:37 am

21 Sep 2026

Friday, 18 September 2026

1 announcement

Memphasys Limited (ASX:MEM)
OperationsPrice Sensitive

Memphasys Signs European Felix Distribution Deal

Memphasys signed a three-year exclusive Felix agreement with INVIDO for Czech Republic, Slovakia and Kazakhstan, with about A$674,000 minimum purchases.

Memphasys Limited (ASX:MEM)

8:45 am

18 Sep 2026

Copyright © 2026 SureStone Capital